Discontinuation report 5% DEXTROSE INJECTION, USP
Report ID | 120961 |
Drug Identification Number | 00060348 |
Brand name | 5% DEXTROSE INJECTION, USP |
Common or Proper name | 5% Dextrose Injection, USP |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 5G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500 mL AVIVA Container (JE0063) |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | 2019-05-07 |
Actual discontinuation date | 2019-05-07 |
Remaining supply date | 2019-05-07 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-07-23 | English | Compare |
v2 | 2020-07-23 | French | Compare |
Showing 1 to 2 of 2